Celebrating
30 years
2026
• 30 year milestone!
• Launched corporate health screening in Malaysia
• Automated sales request intake
2025
• Term sheet with Thailand GPO for ODS distribution
• Regional expansion with APB Bioresources in Malaysia
2023
• IPO fully subscribed on SGX
• Private label supply agreement with McKesson
2022
Halal Certification for Pasture Surgical N95 Respirators
2021
• 5th mask facility opens in Thailand
• 100M+ N95 Respirators supplied globally
• Exclusive Distributor for CanSino COVID-19 vaccine
2020
Planned 5th mask manufacturing facility in Asia
2019
• 4th mask facility based in China
• PIC/S approval for ODS manufacturing
2018
3rd mask manufacturing facility based in China
2017
2nd mask manufacturing facility based in China
2016
• Seven N95 respirators approved by U.S FDA
• Invest in Hart-S, first ODS manufacturing
2014
International Procurement & Distribution of Medicinal Products
2009
• U.S FDA approval of 2 pandemic N95 respirators
• F550G and A520G recommended for H1N1
2007
NIOSH approval for anti-viral mask, first in the world
2005
• R&D investment in anti-viral mask
• Mask manufacturing facility in Taiwan
2003
Largest Supplier of Influenza vaccines to Singapore during SARS
2001
• Exclusive distributor of Chiron Vaccines (Novartis)
• Exclusive distributor of Genzyme SE Asia (Sanofi)
2000
Incorporation of Pacific Biosciences Singapore
1998
Exclusive Distributor for Byk Gulden (Altana)
1996
Incorporation of Pasture Pharma in Singapore
Healthcare distribution built for reliability and scale.
Pasture Group supports pharmaceutical and healthcare companies with regional logistics management, procurement, and cold-chain solutions across Asia and global markets. The Group also operates across healthcare supply, manufacturing support, and consumer-facing businesses.
WHAT DRIVES US
01
Improve quality of life through increased access to healthcare
02
Long-term partnerships
03
Creative and practical solutions backed by science and operations
Need a healthcare distribution partner?
Speak with our team about procurement support, cold-chain infrastructure and how to streamline your healthcare supply chain.
Pasture Holdings Ltd. listed on the Singapore Exchange (SGX) Catalist Board on June 9, 2023 as SGX:UUK
LISTED ON SGX CATALIST
Listed June 2023 – a public commitment to transparency, governance, and long-term growth in healthcare.
SGX:UUK
Experience, resilience, and pride to everything we do.
OUR PEOPLE
Executive Staff
-
Mr. Soong founded the Group in 1996 after seeing an unmet need for a distribution company that focused on specialty medications and medical devices. He oversees the overall business, operations, and performance of the Group. He has over 39 years of experience in the pharmaceutical and medical supplies and devices industry. Mr. Soong has a Master of Business Administration (Strategic Marketing) from the University of Hull, England. Lloyd’s personal interests are rooted in the R&D of innovative products that can improve one’s quality of life.
-
Ms. Ho is responsible for managing the pharmaceutical regulatory affairs for our Group, including controlled drugs management and quality management. She also manages the Group’s daily business operations. Ms. Ho has over 19 years of experience in the pharmaceutical industry. She has a Bachelor of Science (Pharmacy) from the National University of Singapore, and has been certified as a registered pharmacist by the Singapore Pharmacy Board.
-
Mr. Tan holds a BPharm (Hons) and is a registered pharmacist. Before his appointment as Chief Operating Officer (COO), he led Pasture Group's Business Development. With extensive experience in leading teams, driving strategic initiatives, shaping long-term goals, and identifying growth opportunities, Mr. Tan has been pivotal in Pasture’s journey. His expertise in project and division management, fostering strong market relationships, and ensuring operational efficiency remains a cornerstone of Pasture’s success.
-
Ms. Soong has a Bachelor of Commerce from McGill University. She is the Group’s Digital Marketing Manager, overseeing the digitalization, marketing, and “furlife” mobile application. Prior to joining the Group, she was a content strategist at Maker Lab for Google APAC.
-
Mr. Lee is a member of the Association of Chartered Certified Accountants (ACCA) and the Institute of Singapore Chartered Accountants. Mr. Lee has extensive experience in managing investor relations, risk & compliance, and financial services. Prior to joining Pasture, he served as CFO at Memiontec Holdings Limited and CSC Holdings Limited, where he played key roles in driving financial strategy and corporate governance.